Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study

被引：0
|
作者：
Tepper, S. J. [1 ]
Schwedt, T. J. [2 ]
Vo, P. [3 ]
Joshi, P. [4 ]
Glassberg, M. [5 ]
Abdrabboh, A. [5 ]
Ferraris, M. [3 ]
Tiwari, S. [4 ]
Thompson, J. [6 ]
机构：
[1] Dartmouth Hitchcock Dept Neurol, Geisel Sch Med, Hanover, NH USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Healthcare Private Ltd, Value & Access, Hyderabad, Telangana, India
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Kantar Hlth, New York, NY USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL050
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [41] Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or CGRP mAbs: A retrospective claims analysis study
    Schwedt, T. J.
    Lee, J.
    Knievel, K.
    McVige, J. W.
    Wang, W.
    Wu, Z.
    Gillard, P.
    Shah, D.
    Blumenfeld, A. M.
    HEADACHE, 2022, 62 : 81 - 82
  • [42] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study
    Schwedt, T.
    Lee, J.
    Knievel, K.
    McVige, J.
    Wang, W.
    Wu, Z.
    Gillard, P.
    Shah, D.
    Blumenfeld, A.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [43] Real-world treatment patterns, health care resource utilization (HRU), and costs among patients with Waldenstrom macroglobulinemia (WM) initiating therapy
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [44] Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or CGRP mAbs: A Retrospective Claims Analysis Study
    Schwedt, Todd J.
    Lee, Jae
    Knievel, Kerry
    McVige, Jennifer
    Wang, Weiying
    Wu, Zheng
    Gillard, Patrick
    Shah, Darshini
    Blumenfeld, Andrew M.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 18 - 19
  • [45] Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore
    Bayani, Diana Beatriz
    Lin, Yihao Clement
    Ooi, Melissa G.
    Tso, Allison Ching Yee
    Wee, Hwee Lin
    EJHAEM, 2023, 4 (04): : 1013 - 1018
  • [46] Real-World Analysis of Healthcare Resource Utilization and Costs Among Patients Diagnosed with Von Willebrand Disease and Angiodysplasia
    Connell, Nathan T.
    Caicedo, Jorge
    Nieto, Natalia
    Chatterjee, Sagnik
    Hait, Arunima
    Bullano, Michael
    Gupta, Arun
    Schultz, Bob G.
    BLOOD, 2022, 140 : 7885 - 7886
  • [47] Real-world Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Newly Treated Korean Patients With Asthma: A Retrospective Cohort Study
    Choi, Nam-Kyong
    Shantakumar, Sumitra
    Kim, Mi-Sook
    Lee, Chang-Hoon
    Cheng, Wendy Y.
    Bobbili, Priyanka
    Yang, Bo Ram
    Lee, Joongyub
    Hinds, David
    Duh, Mei Sheng
    Korves, Caroline
    Park, Heung-Woo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 220 - 232
  • [48] Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
    Danve, Abhijeet
    Vadhariya, Aisha
    Lisse, Jeffrey
    Cholayil, Arjun
    Bansal, Neha
    Bello, Natalia
    Bakewell, Catherine
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1333 - 1345
  • [49] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
    Rogers, Kerry Anne
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] REAL WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) COSTS OF DIAGNOSTIC REVISION AMONG PATIENTS WITH PERIPHERAL T-CELL LYMPHOMAS (PTCL) IN THE US
    Rebeira, M.
    Bonafede, M.
    McMorrow, D.
    Park, J.
    Feliciano, J.
    Lisano, J.
    Richhariya, A.
    VALUE IN HEALTH, 2019, 22 : S72 - S72
12345